How a new green light therapy device is helping chronic migraine patients go weeks—even entire months—without a single attack.

I'm about to piss off the makers of Aimovig, Emgality, Topamax, and every pharmaceutical company that profits from your migraines.
Because what I'm about to share could cost them millions in lost revenue.
But I don't care anymore.
After reading my patient Jennifer's follow-up form and finding the words "I'm giving up" written across the bottom...
After seeing her describe waking up at 3 a.m. with her right temple already locked in pain, knowing she'd be spending the rest of the day glued to her bed in the dark, missing her granddaughter's birthday she'd been looking forward to for weeks...
After watching the "experts" — including me — put her through 10 years of Imitrex, Topamax, Aimovig, Emgality, and three rounds of Botox, each one working for a few months before her migraines came roaring back worse than before...
I knew the system had failed her.
So I went looking for an answer my field had never put in front of me. And what I found changed everything.
And if you're reading this with a cabnet full of failed medications, a neurologist who keeps adjusting your dose, and more migraine days now than when you first started treatment...
The next 5 minutes could be the most important you spend this year.
I'm Dr. Christopher Caldwell. Headache and pain specialist, 15 years in practice, 3,000+ patients treated.
And after 15 years of prescribing the same medications you've been on — and watching 73% of my chronic migraine patients either never improve or get worse over time.
I can't stay silent about what I found anymore.
But first, let me tell you about the appointment that changed everything.

Three years ago, a woman named Jennifer walked into my office.
She'd had migraines since she was eight years old.
Not the occasional headaches that come and go. The kind that became the architecture of her entire life.
Which schools she could attend. Which jobs she could take. Which relationships she could maintain.
By the time she walked into my office she had tried everything medicine had to offer.
•Imitrex (worked for six months, then stopped)
•Topamax (unbearable side effects, everyday brain fog)
•Aimovig (worked for three months, then stopped)
•Emgality (no effect at all)
•Botox (frozen forehead, left her migraines worse)
Her migraine diary showed 20 to 28 migraine days PER MONTH, most of them spanning several days.
She had been at that level for 10 years.
I reviewed her chart. We had tried every medication class. Adjusted dosages. Tried combinations.
By every standard of care, we had done everything right.
But she was getting worse, not better.
Most patients when they come into my office they bring a phone full of research. A list of questions. Something to fight with.
But when Jennifer came she had nothing.
No list. No questions. No fight left.
She sat down, folded her hands in her lap, and looked at me with the kind of stillness that only comes from someone who has completely given up.
Then she asked me something that stopped me cold.
"Dr. Caldwell, I can't keep living like this. I need to know if there's something out there that fixes what's actually wrong with me. Or if I've just been managing something that was never going to get better "
I didn't have an answer.
And that bothered me more than I wanted to admit.
I'd been treating chronic migraine patients for 15 years. I knew every medication available. Watched them work. Watched them stop.
But Jennifer wasn't asking about medications.
She was asking whether anyone had ever actually looked for the real answer.

Jennifer's words stayed with me long after she left.
In fifteen years of practice, I had heard every version of "why isn't this working anymore" from my patients
What no patient had ever done was tell me they had simply stopped fighting. Because they had stopped believing anything would work.
But Jennifer had.
And sitting there with her chart that night, I had to admit something I had been avoiding the whole time.
Not once had I stopped to ask why each medication kept failing in the first place.
So that night I made it my mission to find an anwser.
I didn't pull out old scans because it's clear whatever was happening inside Jennifer's head was never the kind of thing that shows up on an image.
What I did pull out was eight years of Jennifer's own words.
Every note from every appointment. Everything she had told me, going back to the first days she had migraines.
And what I missed had become obvious.
When Jennifer was still at a young age, her migraines were occasional. They had reasons.
Her period. A bad night of sleep. A glass of wine on the wrong night.
And the pain would always be in the same spots. Right around the brow. The temple. The cheekbone. The jaw on the same side.
That's how it had been for years. But what changed was the frequency.
By her recent appointments, she was getting them nearly every day of the month.
And the list of things that set one off had grown longer every single year.
Her husband's cologne. The pressure before a storm. A room lit with fluorescents. Then entries where she could not name a reason at all.
And that same pain in her right side temple never went away. It was sore even on her good days.
"I feel like existing is a trigger."
She had said that to me two years ago. I had moved past it in the appointment. Switched her medication. Sent her on her way.
But now re-reading these notes I realized she had not become more fragile. Something inside her brain was reacting to EVERYTHING.
And the brow, the temple, the cheekbone, the jaw — those weren't four separate spots she had been pointing to for eight years. They were one nerve.
The trigeminal nerve.

The nerve that carries migraine pain. When it fires, the migraine fires.
That was the nerve. She had known it by feel for years. She had just never been handed its name.
And the question I had never asked in those eight years was simple.
What had happened to that nerve, after years of firing over and over?
Every migraine had left that nerve more sensitive than the one before, and the sensitivity never resets. Hundreds of attacks, each turning it up another notch.
The more sensitive that nerve got, the less it took to set off a migraine.
So they came more often until breathing was enough to set it off.
That climb wasn't Jennifer getting worse. That was the nerve getting more sensitive, year after year.
The nerve was the main factor of all of it. And for eight years, I had been prescribing around it.
Every medication I had ever put her on was built to do the same thing.
Work around the nerve. Quiet the attack. Dampen the signal coming off it.
Her medications had not failed because Jennifer was treatment resistant.
They had failed because not one of them was ever built to solely reach that nerve.

I pulled up Jennifer's prescription history the next morning.
Eight years of refills. Eight years of dose adjustments. Eight years of switching her from one medication to the next.
Every single one designed to work on something around the nerve.
Imitrex? Blocks pain signals from reaching the brain.
Aimovig? Blocks the CGRP protein that triggers attacks.
Emgality? Same mechanism as Aimovig with a different antibody. Doesn't reach the nerve.
Topamax? Slows the entire brain down so the nerve fires less often.
Botox? Paralyzes the muscles around the nerve so the firing can't reach the surface.
Five different medications. Five different mechanisms. Five different ways of working around the nerve.
Not one of them built to touch the nerve itself.
And it was the only way my field had ever bothered to build.
Not because it was the only way it could be done.
Because it was the only way that made anyone money.
A medication a patient takes every day for the rest of her life is a business model.
A treatment that calms her nerve and lets her stop is not.
If I wanted to give Jennifer what she had been asking for, I was going to have to look outside the playbook my field had handed me.
Because the answer was never going to come from inside it.

For weeks I searched.
Not in the journals I had been trained to read. Those journals were never going to have what I was looking for.
So I dug through neuroscience journals my field had never told me to open. Looking for anything that worked directly on the trigeminal nerve.
Most threads led nowhere.
Until I found a 2016 study by Dr. Rami Burstein at Harvard Medical School. A neurologist who had spent his career on the trigeminal nerve.
Burstein's team had been studying why light triggers migraine attacks in the first place.
So he took chronic migraine patients into a darkened room, exposed them to different wavelengths of light one at a time, and measured what happened in the trigeminal nerve.
Every wavelength they tested — blue, red, white, amber — made the nerve fire harder.
But one wavelength didn't.
A narrow band of green light at exactly 520 nanometers.
Did the exact opposite.
This wavelength made the same hypersensitive nerve I had been examining in Jennifer start to reset.
The effect was so undeniable that Burstein had included blind patients in the trial to rule out placebo. Patients who could not see the light at all.
They showed the same results as the people who could see.
But I needed to know if this would hold up beyond just one research paper.
So I searched for every study that had cited Burstein's research.
A 2018 University of Arizona trial had replicated his findings on the patients every neurologist eventually gives up on — the ones who had failed Botox, CGRP injections, every medication available.
After ten weeks of daily green light exposure, those patients reported a 60% reduction in migraine days.
For the first time in fifteen years, I was looking at something that could reach the trigeminal nerve directly.
And I had only found it because I had stopped looking where my field had told me to look.
But now the question that wouldn't leave my mind was this.
How does light reach a nerve buried inside the head?
And the answer was in the way the eye is wired.
When 520nm green light reaches your eyes, it passes through your eyelids and lands on your retina.
From there it travels down the optic nerve into the brain regions responsible for processing light and pain — including the regions that control your trigeminal nerve.
It is the only known wavelength that reaches the trigeminal nerve through this pathway directly.
Not through the bloodstream. Not through suppression of the brain around the nerve.
Through the visual system itself — even with your eyes closed.
Here is what happens at the neurological level once the signal arrives:
Green light triggers the brain to release its own natural pain-relieving compounds. The same compounds the body produces when it manages pain on its own.
With consistent exposure, the sensitivity that had built up over years of migraines begins to release.
The reactive nerve I had watched climb in patient after patient was actually capable of resetting
Like physical therapy for a nerve that had spent years getting more reactive.
As the trigeminal nerve resets, it takes more to trigger a migraine attack.
Light, weather, food, hormones, stress.
These triggers had stopped pushing the nerve over the edge.
This is not pain blocking.
This is not symptom management.
This is not slowing the brain around the nerve to reach it.
This is the only known mechanism that reaches the trigeminal nerve directly without suppressing anything else to get there.
The science was sound. The results were repeating across institutions.
But there was only one problem left.
I needed a device that could actually deliver 520nm light at the precision the research required.

So I started looking.
Lamps. Bulbs. Glasses. Panels. Anything claiming to deliver green light therapy.
The deeper I looked, the stranger it got.
Most products were emitting green light somewhere in the 500 to 570 nanometer range. Broad spectrum. No clinical specifications.
None of them anywhere close to the narrow-band 520nm the research used.
I couldn't figure out why they had been built that way.
Until I started reading what they were actually designed for.
A lamp marketed for sleep. A panel for mood.
Glasses for relaxation.
Skincare devices for hyperpigmentation.
Every single one of them built for something else entirely.
None designed to deliver the precise narrow-band 520nm at clinical intensity.
None designed to reach the trigeminal nerve.
So my team made a decision.
If the right device did not exist we would build it ourselves.
So we partnered with biomedical engineers who specialized in phototherapy and gave them one brief — replicate the exact conditions of the Harvard and Arizona trials in something patients could use at home.
Months of development. Rounds of testing. Version after version until it met the standard the research demanded.
Then we had it.
Vivée.

Vivée is a medical-grade green light therapy device, calibrated to exactly 520 nanometers
Designed as a soft, lightweight face mask. Worn over the eyes for ten minutes a day. Eyes open or closed.
Rechargeable. Quiet. No prescription. No setup.
Built to three specifications nobody else on the market was meeting:
✅Precisely calibrated to 520nm. Narrow-band, not broad-spectrum. The exact wavelength the research validated.
✅Clinical-grade light intensity. Calibrated to the same exposure level the trials used. Strong enough to reach the trigeminal nerve through the optic pathway, gentle enough for daily use.
✅Designed for daily home use. No appointments. No ongoing prescriptions. Ten minutes a day, on your own time, in your own space.
This was not a wellness product. It was not a consumer lamp.
It was the first device built to do for a patient at home what every medication had failed to do.

Jennifer's annual appointment was the following month.
I told her what I'd found. The nerve. The Harvard and Arizona research.
And most importantly, Vivée.
She listened quietly.
Then she said something that stopped me.
"So I'm not broken?"
"No," I said. "The approach was wrong. Not you."
Silence.
Then: "Okay. I'll try it."

Jennifer wasn't the only one.
Over the next year I started recommending Vivée to more of my patients.
The ones who had tried everything.
The ones who had given up.
Here's what happened.

Maria came to me after missing her daughter's first school play.
Her third migraine that month had hit the morning of the performance.
She'd been the mom who cancelled. Who apologized. Who watched her daughter's face fall one too many times.

Linda had been labeled treatment resistant for six years.
Botox. Aimovig. Emgality. Three rounds of each.
All of them worked briefly then stopped.
She came to me having given up on the idea that anything would ever work long term.
She wasn't alone.
"16 days without a migraine. I genuinely forgot what that felt like. This gave me my life back." — Sarah
In the past two years I've recommended Vivée to over 500 chronic migraine patients.
The ones who see the most dramatic results?
The ones who have been suffering the longest. The ones who had tried everything.
Because they have the most nerve hypersensitivity to retrain.

I'm not saying you'll never have another migraine.
But imagine going from 15-20+ migraine days per month to 2-3. Or even 0.
Imagine going weeks—not days, but weeks—without that crushing pain, nausea, and light sensitivity.
Imagine booking that trip you've been putting off for years and actually going. Showing up to every dinner, every birthday, every weekend.
That's what happens when you retrain your hypersensitive nervous system instead of just blocking pain signals through an overreactive brain.

I want to be honest with you about what I see in my practice.
The average chronic migraine patient who waits five years before addressing the trigeminal nerve directly doesn't stay where they are.
They get worse.
Migraine days go from 8-10 per month to 15-20.
Preventative medication count goes from 1 to 3.
Triptan use doubles.
Stroke risk increases significantly with every year of uncontrolled chronic migraine.
Five years from now, the version of you who took action this month will be at fewer migraine days than you have right now.
The version who waited will be at more. On more medications. With more side effects. With more years of "we've tried everything" appointments behind her.
Every migraine between now and when you address the nerve is making the next attack easier to trigger. The threshold doesn't reset on its own.
The nerve doesn't stop sensitizing because you're tired of it sensitizing.
I have watched too many patients regret how long they waited.
Jennifer waited thirty years because nobody told her this existed.

If you've decided you want to try addressing the nerve directly, Vivée is what I recommend to all of my patients.
Right now it's on a limited time for $195 — $55 off the regular price, with free shipping. Less than one month of preventative medication
Compare that to:
• 3 months of side effects before you know if it works
• Preventative medications that stopped working ($600+ in prescriptions with insurance)
• More migraine days each year despite doing everything right
You get 60 days to see if your migraine days drop. If they don't, you get every penny back.
You're not risking $195. You're testing whether addressing the nerve at the source can give you your life back.
You can try Vivée risk-free for 60 days.
I became a neurologist because I wanted to give people their lives back.
Not manage their condition. Not find the next medication to try.
Actually give them their lives back.
The ability to make a plan and keep it. To show up for the people they love. To wake up and not immediately wonder if today is going to be a good day or a lost one.
That's what I want for you.
I hope this is the thing that finally does it.
— Dr. Christopher Caldwell
Headache & Pain Specialist
15 years in practice | 3,000+ patients treated


Join 100,000+ People Using
Medical-Grade Green Light To
Reduce Migraines At The
Cellular Level
© 2025 Vivée. All Rights Reserved. Privacy Policy Terms of Use
DISCLAIMER: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before starting any new treatment.
THIS IS AN ADVERTISEMENT AND NOT AN ACTUAL NEWS ARTICLE, BLOG, OR CONSUMER PROTECTION UPDATE